RARumeysa Nur Akbaş

Rumeysa Nur Akbaş

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rumeysa Nur Akbaş has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The relationship between executive functions and daily auditory behaviors in preschool cochlear implant users

    by Rumeysa Nur Akbaş, Ayşe Özer

    Hearing loss affects millions of children globally, posing a significant challenge to neurodevelopmental trajectories. The World Health Organization estimates that nearly 60% of childhood hearing l...

  • Open Access

    Newborn hearing screening: outcomes and management of infants

    by Hatice Kübra Bozkurt, Fatma Ceyda Akın Öçal, Ercan Karababa, Ayşe Nur Balaban, Rumeysa Nur Akbaş, Öykü Özbaş Kes, Emine Aydın

    SUMMARY OBJECTIVE: The aim of this study was to evaluate the prevalence and characteristics of hearing loss among infants referred after newborn hearing screening in a tertiary referral center in Türkiye and to examine its association with demographic and clinical risk factors. METHODS: A retrospective study was conducted at SBÜ Gülhane Training and Research Hospital between January 2021 and December 2024, including 1,322 infants referred after newborn hearing screening due to either a "refer" result or the presence of risk factors despite passing automated auditory brainstem response. Relevant risk factors were analyzed. RESULTS: Hearing loss was detected in 92 infants (7.0%), including 3.3% with unilateral and 3.7% with bilateral loss. By severity, the distribution was mild (2.8%), moderate (0.8%), moderately severe (0.3%), and profound (1.5%). While most infants with unilateral loss did not receive amplification, bilateral cases showed higher rates of hearing aid (28.6%) and cochlear implant (14.3%) use. Family history of hearing loss was the only factor significantly associated with device adoption (p<0.05). CONCLUSION: The prevalence of hearing loss in referred infants was higher than in population-based studies and aligned with findings in high-risk groups. Differences in device use between unilateral and bilateral cases highlight the importance of parental counseling. Strengthening follow-up and family awareness is crucial to improving early intervention outcomes, particularly in infants without a family history.

  • Psychosocial Status and Quality of Life in Patients With Ménière's Disease and Vestibular Migraine

    by Ercan Karababa, Fatma Ceyda Akın Öçal, Rumeysa Nur Akbaş, Abdullah Sunar, Emine Aydın

    Purpose: The objective of this study was to evaluate anxiety, depression, dizziness disability, sleep, and quality of life in individuals diagnosed with Ménière's disease (MD) and vestibular migraine (VM). Additionally, the study sought to examine the impact of anxiety and depression levels, as well as dizziness disability, on sleep and quality of life. Method: The present study included a total of 51 individuals, with 25 subjects in the MD group and 26 subjects in the VM group. The Beck Anxiety Inventory (BAI), the Beck Depression Inventory (BDI), the Dizziness Handicap Inventory (DHI), the 36-Item Short Form Health Survey (SF-36) for quality of life, and the Pittsburgh Sleep Quality Index (PSQI) were administered face-to-face to all subjects. Results: A statistically significant difference was not observed between the two groups in terms of BDI, BAI, DHI total, and subcategories (Emotional, Physical, and Functional; p > .05). Among the subdimensions of SF-36, only Vitality and Mental Health scores were found to be statistically significantly higher in the MD group compared to the VM group ( p = .039 and p = .030, respectively). Conversely, the PSQI score exhibited a statistically significant difference, with higher values observed in the VM group compared to the MD group ( p = .023). Conclusions: VM and MD significantly impact psychological and physiological outcomes, including anxiety, depression, dizziness, quality of life, and sleep. Psychiatric comorbidities and reduced quality of life profoundly affect daily life. Therefore, a multidisciplinary approach, including psychiatric support, is essential for effective management.


  • Open Access

    Prevalence of Anxiety and Depression in Patients Diagnosed with Vestibular Neuritis or Benign Paroxysmal Positional Vertigo

    by Fatma Ceyda Akın Öçal, Ercan Karababa, Rumeysa Nur Akbaş Gülek, Abdullah Sunar, Emine Aydın

    Background: Benign paroxysmal positional vertigo (BPPV) is a disorder characterized by episodic vertigo attacks lasting seconds triggered by head position. Vestibular neuritis (VN) is a disorder of peripheral origin with symptoms such as severe vertigo, nausea, and vomiting in the acute phase. Both BPPV and VN are among the most common causes of vertigo. In clinical practice, many individuals with peripheral vestibular disor ders also suffer from psychological symptoms such as depression and anxiety. The aim of this study was to determine the levels of anxiety and depression in patients diagnosed with BPPV or VN in the acute stage. Methods: This cross-sectional study included 46 patients with BPPV and 26 with VN aged between 18 and 65 years who presented to the otorhinolaryngology outpatient clinic with complaints of dizziness. Data were collected within 48 hours of symptom onset. The Beck Anxiety Inventory (BAI), the Beck Depression Inventory (BDI), and the Dizziness Handicap Inventory (DHI) were used to collect data. Results: There was no statistically significant difference in the BAI, BDI, and DHI subscores (physical, emotional, and functional) and total scores between the BPPV and VN groups (P-values ranging from .324 to .915). However, DHI scores in both groups indicated moderate dizziness dis ability, while BDI scores were minimal in both groups. Although BAI scores were moderate in both groups, higher scores were observed in the VN group compared to the BPPV group. Conclusion: Psychological symptoms frequently accompany vestibular disorders, such as BPPV and VN. In conjunction with medical treatment, providing psychological support can enhance the overall management of vertigo in affected patients. Cite this article as: Öçal FCA, Karababa E, Akba! Gülek RN, Sunar A, Aydın E. Prevalence of anxiety and depression in patients diagnosed with vestibular neuritis or benign paroxysmal positional vertigo. B-ENT. 2025;21(1):24-30.

  • Open Access

    Virtual Reality Technology in Vestibular Rehabilitation

    by Rumeysa Nur Akbaş

    Denge, vücudun ağırlık merkezini destek tabanı üzerinde tutma yeteneğidir. Dengenin sürdürülmesi, santral sinir sisteminin vestibüler, görsel ve proprioseptif sistemlerden gelen duyusal girdiyi koordine ettiği ve bütünleştirdiği karmaşık bir etkileşim ile sağlanır. Bu sistemlerden herhangi biri hasar gördüğünde veya yetersiz kaldığında, bireylerin denge işlevleri belirgin şekilde etkilenir ve baş dönmesine neden olur. Vestibüler bozuklukların tedavisinin temel dayanağı olan vestibüler rehabilitasyon, baş dönmesi, yaşam kalitesinin ve denge kontrolünün iyileşmesine olanak tanır. Vestibüler rehabilitasyon için sanal gerçeklik teknolojisinin kullanılması, daha gerçekçi ve sürükleyici bir ortamın simüle edilmesini sağlar. Bu sayede bireyin ilgisini daha fazla çekerek rehabilitasyona uyumunu artırır. Geleneksel vestibüler rehabilitasyon seanslarının uzun süreli ve maliyetinin yüksek olması, seans sırasında hasta kooperasyonu gerektirmesi gibi dezavantajlarından dolayı başarısızlıkla sonuçlanabilir. Sanal gerçeklik temelli vestibüler rehabilitasyon, geleneksel vestibüler rehabilitasyonun yerini alabilir veya katkıda bulunabilir.